The intent of this grant mechanism is to provide interim support for promising cancer-related investigator-initiated research projects that have been highly rated by national panels of peer reviewers in recent federal competitions but were not funded due to budgetary constraints. Allowable federal competitions include those conducted by the National Institutes of Health (including the National Cancer Institute), the Department of Defense Congressionally Directed Medical Research Programs for Breast Cancer Research or Prostate Cancer Research, the National Science Foundation, the Agency for Healthcare Research and Quality, the Health Resources and Services Administration, the Centers for Disease Control and Prevention, and the Food and Drug Administration.
The maximum award for Bridge grants is $200,000 over a 12-month period and is expected to start July 1 and end the following year on June 30.
The intent of this program is to foster development of new investigators so that they can undertake independent research that is competitive for national research funding. Projects are carried out under the mentorship of a senior investigator. Proposals must address an important biomedical or behavioral problem relevant to tobacco-related disease.
The maximum annual award for NIR grants is $125,000 with a maximum of $375,000 over a 36-month period (amounts subject to change). Initial awards are for a period of 12-months and are expected to start July 1 and end the following year on June 30.
The intent of this grant mechanism is to assemble and prepare strong interdisciplinary teams of Florida researchers to plan and compete successfully for SPORE grants offered by the National Cancer Institute.
The maximum annual award for SPORE Planning grant is $500,000 with a maximum of $1,000,000 over a 36-month period (amounts subject to change). Initial awards are for a period of 12-months and are expected to start July 1 and end the following year on June 30.
The intent of this grant mechanism is to increase the likelihood of success in research projects including clinical trials and studies involving live human subjects (behavioral, social and epidemiological studies). The grant will support complete planning and design of, and documentation for, clinical trials or studies involving live human subjects.
The maximum award for CRP grants is $100,000 over a 12-month period and is expected to start July 1 and end the following year on June 30.
Note: The above grant mechanisms were offered in the FY 2008-2009 Call for Grant Applications. The mechanisms may change in the next Call for Grant Applications document.
The Bankhead-Coley Cancer Research Program Call for Grant Application document for the FY 2009-2010 is anticipated to be released in December 2008. If you are interested in receiving notices and announcements about the Bankhead-Coley Cancer Research Program, please subscribe on the home page of this website.
Award notifications were issues on May 30, 2008. To review the award announcement article, click on the following link:
FY 2008-09 King and Bankhead-Coley Programs Grant Awards Announcement
To review the Call for Grant Applications document for the FY 2008-2009 Program, click on the following links:
Bankhead-Coley Call For Grant Applications FY 2008-2009
Bankhead-Coley Call Amendment
Check this web site often for updates and new information.
The Bankhead-Coley Cancer Research Program Call for Grant Application document for the FY 2009-2010 is anticipated to be released in December 2008. Details about how to submit Call questions will be included in the Call document. If you are interested in receiving notices and announcements about the Bankhead-Coley Cancer Research Program, please subscribe on the home page of this website.
The Bankhead-Coley Cancer Research Program Call for Grant Application document for the FY 2009-2010 is anticipated to be released in December 2008. If you are interested in receiving notices and announcements about the Bankhead-Coley Cancer Research Program, please subscribe on the home page of this website.
